#drug-supplies
Cipla looks to ensure consistent drug supplies, as costs increase due to West Asia war, says MD & Global CEO
The company’s net profit at Rs ₹555 crore for the quarter under review was down 55 per cent from Rs ₹1,222 crore in the same period last year
Cipla looks to ensure consistent drug supplies, as costs increase due to West Asia war, says MD & Global CEO
The company’s net profit at Rs ₹555 crore for the quarter under review was down 55 per cent from Rs ₹1,222 crore in the same period last year